What are the causes of low insulin levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Low Insulin Levels

Low insulin levels result primarily from autoimmune destruction of pancreatic beta-cells (type 1 diabetes), progressive beta-cell failure in type 2 diabetes, or rarely from paradoxical insulinoma presentations.

Primary Causes

Type 1 Diabetes (Autoimmune Beta-Cell Destruction)

The most common cause of truly low insulin levels is immune-mediated destruction of pancreatic beta-cells, which leads to little or no insulin secretion manifested by low or undetectable plasma C-peptide levels 1. This process:

  • Occurs through autoimmune mechanisms with multiple genetic factors (particularly HLA-DQB1 and DRB1 haplotypes)
  • Can present at any age, though most common in childhood and adolescence
  • Progresses through three stages, with stage 3 representing complete beta-cell failure
  • Results in absolute insulin deficiency requiring exogenous insulin for survival 1

The rate of beta-cell destruction varies considerably—rapid in infants and children (often presenting with DKA), slower in adults who may retain some function for years before becoming insulin-dependent 1.

Type 2 Diabetes (Relative Insulin Deficiency)

While type 2 diabetes classically involves insulin resistance, beta-cell dysfunction and progressive insulin deficiency are sine qua non for diabetes development 2. The insulin secretory deficit in type 2 diabetes is:

  • Functionally severe but anatomically modest (20-40% reduction in beta-cell mass) 2
  • Progressive and worsening with disease duration
  • Partially acquired through glucotoxicity (hyperglycemia-induced reduced insulin biosynthesis) and lipotoxicity (elevated free fatty acids accelerating beta-cell apoptosis) 3, 4
  • Demonstrable both at baseline and after stimulation 5

Critical distinction: Beta-cell dysfunction must be present for diabetes to occur, but insulin resistance determines whether this dysfunction manifests as overt diabetes 2.

Secondary and Rare Causes

Idiopathic Type 1 Diabetes

Some individuals develop permanent insulinopenia and DKA susceptibility without detectable autoantibodies or known etiology 1. This represents a distinct subgroup requiring the same insulin replacement as autoimmune type 1 diabetes.

Viral Triggers

Several viruses can damage beta-cells:

  • Enteroviruses (Coxsackievirus B)
  • SARS-CoV-2 (COVID-19), which increased cases of new-onset diabetes through direct beta-cell damage, immune-mediated destruction, or inflammatory cytokine effects 1

Checkpoint Inhibitor-Associated Diabetes

Patients receiving immune checkpoint inhibitors can develop rapid-onset type 1 diabetes, particularly those with predisposing HLA haplotypes 1. This cannot be predicted by family history or autoantibodies, requiring vigilant monitoring.

Paradoxical Insulinoma Presentation

A critical pitfall: Insulinomas can rarely present with inappropriately low measured insulin levels despite elevated C-peptide 6. This occurs because:

  • The tumor may secrete proinsulin or insulin precursors
  • C-peptide remains elevated, providing the diagnostic clue
  • Hypoglycemia with low insulin but elevated C-peptide should prompt imaging for neuroendocrine tumors 6

Diagnostic Approach

When evaluating low insulin levels:

  1. Measure C-peptide simultaneously—this distinguishes true beta-cell failure from assay issues or paradoxical presentations 6
  2. Check for autoantibodies (GAD, IA-2, ZnT8, insulin autoantibodies) to identify autoimmune etiology 1
  3. Assess clinical context: DKA, age of onset, obesity status, family history
  4. Consider genetic testing in atypical presentations or family history suggesting monogenic diabetes 3

Key Clinical Pitfalls

  • Don't assume obesity excludes type 1 diabetes—obesity is increasingly common in the general population and doesn't preclude autoimmune beta-cell destruction 1
  • Don't dismiss low insulin with hypoglycemia—always check C-peptide to rule out insulinoma 6
  • Don't attribute all low insulin to type 1 diabetes—progressive type 2 diabetes causes significant insulin deficiency requiring insulin therapy 2
  • Monitor patients on checkpoint inhibitors regardless of diabetes risk factors, as onset can be rapid and unpredictable 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.